SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001193125-11-293328
Filing Date
2011-11-03
Accepted
2011-11-02 20:32:46
Documents
5
Period of Report
2011-06-30
Filing Date Changed
2011-11-02

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-Q d250302d10qa.htm 10-Q/A 26985
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER UNDER SECTION 302 d250302dex311.htm EX-31.1 7402
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER UNDER SECTION 302 d250302dex312.htm EX-31.2 7389
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER d250302dex321.htm EX-32.1 4352
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER d250302dex322.htm EX-32.2 4340
  Complete submission text file 0001193125-11-293328.txt   51817
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 033-17264-NY | Film No.: 111175840
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1